Literature DB >> 17535202

Heterozygous prothrombin gene mutation associated with livedoid vasculopathy.

Namrata S Anavekar1, Robert Kelly.   

Abstract

A 53-year-old woman presented with a chronic history of recurrent, painful ulcers, predominantly involving her lower legs. Both her clinical picture and histopathological findings were consistent with a diagnosis of livedoid vasculopathy, although she did have unusual findings of deep tender nodules and the presence of lesions over her elbows. Multiple investigations were undertaken, the only abnormality being a heterozygous mutation of the prothrombin G2021A gene. Although various coagulopathic states have been associated with livedoid vasculopathy, the finding of an associated prothrombin gene mutation is quite rare. Warfarin has ameliorated the clinical course when anti-inflammatory drugs and other anticoagulants were unhelpful.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17535202     DOI: 10.1111/j.1440-0960.2007.00350.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  4 in total

1.  Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity.

Authors:  Noha A Irani-Hakime; Farid Stephan; Raghid Kreidy; Isabelle Jureidini; Wassim Y Almawi
Journal:  J Thromb Thrombolysis       Date:  2008-03-23       Impact factor: 2.300

2.  Ulcerative livedoid vasculopathy responding to clopidogrel.

Authors:  Elaine Kunzler; Benjamin F Chong
Journal:  JAAD Case Rep       Date:  2018-02-03

3.  Painless Livedoid Vasculopathy in a Patient with G20210A Prothrombin Gene Mutation.

Authors:  Aibek E Mirrakhimov; Erwin Velasquez Kho; Alaa Ali
Journal:  Case Rep Med       Date:  2012-09-05

4.  Reticulate dermatoses.

Authors:  Keshavmurthy A Adya; Arun C Inamadar; Aparna Palit
Journal:  Indian J Dermatol       Date:  2014-01       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.